Company Profiles

driven by the PitchBook Platform

Delphinus Medical Technologies

Delphinus Medical Technologies
2010 FOUNDED
PRIVATE STATUS
51-200 EMPLOYEES
Series C2 LATEST DEAL TYPE
$8.23M LATEST DEAL AMOUNT
$70.7M TOTAL AMOUNT RAISED
Description

Developer of a breast ultrasound system designed to tenaciously create and deliver medical innovations that will transform early detection of breast cancer and save women's lives all over the world. The company's breast ultrasound system differentiates benign from malignant masses in breast cancer cases, enabling medical professionals better define and diagnose breast disease and provide better patient experience for women regardless of age, without concern of radiation or discomfort.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Decision/Risk Analysis
Primary Office
45525 Grand River Avenue
Novi, MI 48374
United States

+1 (248) 522-9600
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Delphinus Medical Technologies’s full profile, request a free trial.

Delphinus Medical Technologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Later Stage VC (Series C2) 19-Apr-2017 $8.23M $70.7M 000.00 Completed Pre-Clinical Trials
9. Grant 01-Jan-2016 00.000 000.00 Completed Pre-Clinical Trials
8. Later Stage VC (Series C) 10-Sep-2015 000.00 000.00 0000 Completed Startup
7. Grant 01-Jan-2015 00000 0000 Completed Pre-Clinical Trials
6. Grant 01-Jan-2014 00000 0000 Completed Startup
5. Later Stage VC (Series B) 04-Sep-2013 0000 0000 000.00 Completed Startup
4. Grant 01-Jan-2013 00000 0000 Completed Startup
3. Grant 01-Jan-2012 00.000 0000 Completed Startup
2. Grant 29-Oct-2010 $11M Completed Startup
1. Early Stage VC (Series A) 01-Sep-2010 $11M $11M $15.6M Completed Startup
To view this company’s complete deal history including valuation and funding request access »

Delphinus Medical Technologies Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series C-2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.00
Series C-1 0,000,000 00.000000 00 00.0 00.0 00 00.0 0.000
Series C 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Series B 9,476,726 $0.001000 8% $1 $1 1x $0.71 10.72%
Series A 9,550,000 $0.001000 8% $1 $1 1x $0.68 11.27%
To view this company’s complete Cap Table request access »

Delphinus Medical Technologies Investors (13)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Arboretum Ventures Venture Capital Minority 000 0000 000000 0
Beringea PE/Buyout Minority 000 0000 000000 0
Hopen Life Science Ventures Venture Capital Minority 000 0000 000000 0
Invest Detroit Ventures Venture Capital Minority 000 0000 000000 0
Invest Michigan Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 13 investors. Get the full list »

Delphinus Medical Technologies Executive Team (7)

Name Title Board
Seat
Contact
Info
Mark Forchette President, Board Member & Chief Executive Officer
Shawn O'Brien Chief Financial Officer
Neb Duric Ph.D Chief Technology Officer, Technology & Co-Founder
Heather Rone Vice President, Clinical Affairs
Francis Dobscha Vice President, Quality Assurance And Regulatory Affairs
You’re viewing 5 of 7 executives. Get the full list »

Delphinus Medical Technologies Board Members (10)

Name Representing Role Since Contact
Info
Hugo Braun North Coast Technology Investors Board Member 000 0000
John Neis Venture Investors Board Member 000 0000
Michael Fulton MD Hopen Life Science Ventures Board Member 000 0000
Michael Gross Beringea Board Member 000 0000
Paul McCreadie Arboretum Ventures Board Member 000 0000

4 Former Board Members

You’re viewing 5 of 10 board members. Get the full list »